The Syrian hamster embryo (SHE) assay (pH 6.7): Mechanisms of cell transformation and application of vibrational spectroscopy to objectively score endpoint alterations

Mutagenesis

Volumn 27, Issue 3, 2012, Pages 257-266

  Ahmadzai, Abdullah A ^a   Trevisan, Júlio ^a   Fullwood, Nigel J ^b   Carmichael, Paul L ^c   Scott, Andrew D ^c   Martin, Francis L ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

^c UNILEVER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL STRUCTURE; CELL TRANSFORMATION; CYTOTOXICITY; EMBRYO DEVELOPMENT; INFRARED SPECTROSCOPY; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; SYRIAN HAMSTER;

ANIMALS; CARCINOGENS; CELL PROLIFERATION; CELL SHAPE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CRICETINAE; EMBRYO, MAMMALIAN; MESOCRICETUS; NEOPLASM TRANSPLANTATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84860139691     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger086     Document Type: Review

References (106)

1. Berwald, Y. and Sachs, L. (1963) In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons. J. Natl. Cancer Inst., 35, 641-661.
2. LeBoeuf, R. A., Kerckaert, G. A., Aardema, M. J., Gibson, D. P., Brauninger, R. and Isfort, R. J. (1996) The pH 6.7 Syrian hamster embryo cell transformation SHE assay for assessing the carcinogenic potential of chemicals. Mutat. Res., 356, 85-127.
3. Ridder, G. M., Stuard, S. B., Kerckaert, G. A., Cody, D. B., LeBoeuf, R. A. and Isfort, R. J. (1997) Computerized image analysis of morphologically transformed and nontransformed Syrian hamster embryo (SHE) cell colonies: application to objective SHE cell transformation assay scoring. Carcinogenesis, 18, 1965-1972.
4. Isfort, R. J. and LeBoeuf, R. A. (1995) The Syrian hamster embryo (SHE) cell transformation system: a biologically relevant in vitro model-with carcinogen predicting capabilities-of in vivo multistage neoplastic transformation. Crit. Rev. Oncog., 6, 251-260.
5. Isfort, R. J., Kerckaert, G. A. and LeBoeuf, R. A. (1996) Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals. Mutat. Res., 356, 11-63.
6. Barrett, J. C. (1979) The progressive nature of neoplastic transformation of Syrian hamster embryo cells in culture. Prog. Exp. Tumor Res., 24, 17-27.
7. Gilmer, T. M., Annab, L. A. and Barrett, J. C. (1988) Characterization of activated proto-oncogenes in chemically transformed Syrian hamster embryo cells. Mol. Carcinog., 1, 180-188.
8. Aardema, M. J., Crosby, L. L., Gibson, D. P., Kerckaert, G. A. and LeBoeuf, R. A. (1996) Aneuploidy and consistent structural chromosome changes associated with transformation of Syrian hamster embryo cells. Cancer Genet. Cytogenet., 96, 140-150.
9. Harvey, J. S., Howe, J. R., Lynch, A. M. and Rees, R. W. (2005) The results of five coded compounds: genistein, metaproterenol, rotenone, p-anisidine and resorcinol tested in the pH 6.7 Syrian hamster embryo cell morphological transformation assay. Mutagenesis, 20, 51-56.
10. Barrett, J. C. and Ts'o, P. O. (1978) Evidence for the progressive nature of neoplastic transformation in vitro. Proc. Natl. Acad. Sci. U S A, 75, 3761-3765.
11. LeBoeuf, R. A., Kerckaert, G. A., Aardema, M. J. and Gibson, D. P. (1990) Multistage neoplastic transformation of Syrian hamster embryo cells cultured at pH 6.70. Cancer Res., 50, 3722-3729.
12. Isfort, R. J., Cody, D. B., Doersen, C. J., Kerckaert, G. A. and Leboeuf, R. A. (1994) Alterations in cellular differentiation, mitogenesis, cytoskeleton and growth characteristics during Syrian hamster embryo cell multistep in vitro transformation. Int. J. Cancer, 59, 114-125.
13. LeBoeuf, R. A. and Kerchaert, G. A. (1987) Enhanced morphological transformation of early passage Syrian hamster embryo cells cultured in medium with a reduced bicarbonate concentration and pH. Carcinogenesis, 8, 689-697.
14. Walsh, M. J., Bruce, S. W., Pant, K., Carmichael, P. L., Scott, A. D. and Martin, F. L. (2009) Discrimination of a transformation phenotype in Syrian golden hamster embryo (SHE) cells using ATR-FTIR spectroscopy. Toxicology, 258, 33-38.
15. Isfort, R. J., Kerckaert, G. A., Cody, D. B., Carter, J., Driscoll, K. E. and LeBoeuf, R. A. (1996) Isolation and biological characterization of morphological transformation-sensitive Syrian hamster embryo cells. Carcinogenesis, 17, 997-1005.
16. Isfort, R. J., Kerckaert, G., Anderson, N. L. and LeBoeuf, R. A. (1992) Two-dimensional gel electrophoresis analysis of Syrian hamster embryo cells: morphological transformation is not cell type specific. Electrophoresis, 13, 855-861.
17. Pienta, R. J., Poiley, J. A. and Lebhertz, W. B., III (1977) Morphological transformation of early passage golden Syrian hamster embryo cells derived from cryopreserved cultures as a reliable in vitro bioassay for identifying diverse carcinogens. Int. J. Cancer, 19, 642-655.
18. Isfort, R. J., Cody, D. B., Kerckaert, G. A. and LeBoeuf, R. A. (1994) Growth factor responsiveness and alterations in growth factor homeostasis in Syrian hamster embryo cells during in vitro transformation. Carcinogenesis, 15, 1203-1209.
19. Kerckaert, G. A., Brauninger, R., LeBoeuf, R. A. and Isfort, R. J. (1996) Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays. Environ. Health Perspect., 104, 1075-1084.
20. Haseman, J. K. and Clark, A. M. (1990) Carcinogenicity results for 114 laboratory animal studies used to assess the predictivity of four in vitro genetic toxicity assays for rodent carcinogenicity. Environ. Mol. Mutagen., 18, 15-31.
21. Farmer, P. B. (2002) ILSI/HESI research programme on alternative cancer models: results of Syrian hamster embryo cell transformation assay. Toxicol. Pathol., 30, 536-538.
22. Matthews, E. J., Spalding, J. W. and Tennant, R. W. (1993) Transformation of BALB/c-3T3 Cells: transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays. Environ. Health Perspect., 101 (Suppl. 2), 347-482.
23. Barrett, J. C., Hesterberg, T. W. and Thomassen, D. G. (1984) Use of cell transformation systems for carcinogenicity testing and mechanistic studies of carcinogenesis. Pharmacol. Rev., 36, 53-70.
24. DiPaolo, J. A. and Donovan, P. J. (1967) Properties of Syrian hamster cells transformed in the presence of carcinogenic hydrocarbons. Exp. Cell Res., 48, 361-377.
25. Isfort, R. J., Cody, D. B., Kerckaert, G. A., Tycko, B. and LeBoeuf, R. A. (1997) Role of the H19 gene in Syrian hamster embryo cell tumorigenicity. Mol. Carcinog., 20, 189-193.
26. Bartolomei, M. S., Zemel, S. and Tilghman, S. M. (1991) Parental imprinting of the mouse H19 gene. Nature, 351, 153-155.
27. Leighton, P. A., Ingram, R. S., Eggenschwiler, J., Efstratiadis, A. and Tilghman, S. M. (1995) Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature, 375, 34-39.
28. Blythe, N. L., Senior, P. V. and Beck, F. (1996) Expression of insulin-like growth factor II (IGF-II) and H19 in murine teratocarcinomas derived from embryonic stem (ES) cells. J. Anat., 188, 65-74.
29. Alexandre, S., Rast, C., Maire, M. A., Orfila, L. and Vasseur, P. (2003) ZnCl2 induces Syrian hamster embryo (SHE) cell transformation. Toxicol. Lett., 142, 77-87.
30. Maire, M. A., Rast, C., Pagnout, C. and Vasseur, P. (2005) Changes in expression of bcl-2 and bax in Syrian hamster embryo (SHE) cells exposed to ZnCl2. Arch. Toxicol., 79, 90-101.
31. Adams, J. M. and Cory, S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science, 281, 1322-1326.
32. Maire, M. A., Rast, C., Landkocz, Y. and Vasseur, P. (2007) 2,4- Dichlorophenoxyacetic acid: effects on Syrian hamster embryo (SHE) cell transformation, c-Myc expression, DNA damage and apoptosis. Mutat. Res., 631, 124-136.
33. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Brooks, M., Waters, C. M., Penn, L. Z. and Hancock, D. C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
34. Soucie, E. L., Annis, M. G., Sedivy, J., Filmus, J., Leber, B., Andrews, D. W. and Penn, L. Z. (2001) Myc potentiates apoptosis by stimulating bax activity at the mitochondria. Mol. Cell Biol., 21, 4725-4736.
35. Prendergast, G. C. (1999) Mechanisms of apoptosis by c-Myc. Oncogene, 18, 2967-2987.
36. Watanabe, M. and Suzuki, K. (1991) Expression dynamics of transforming phenotypes in X-irradiated Syrian golden hamster embryo cells. Mutat. Res., 249, 71-80.
37. Hayflick, L. (1976) The cell biology of human aging. N. Engl. J. Med., 295, 1302-1308.
38. Sasaki, M., Honda, T., Yamada, H., Wake, N., Barrett, J. C. and Oshimura, M. (1994) Evidence for multiple pathways to cellular senescence. Cancer Res., 54, 6090-6093.
39. Greider, C. W. (1994) Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr. Opin. Genet. Dev., 4, 203-211.
40. Laderoute, M. P. (1994) A new perspective on the nature of the cancer problem: anti-cellular senescence. Mol. Carcinog., 10, 125-133.
41. Venable, M. E., Blobe, G. C. and Obeid, L. M. (1994) Identification of a defect in the phospholipase D/diacylglycerol pathway in cellular senescence. J. Biol. Chem., 269, 26040-26044.
42. Koi, M. and Barrett, J. C. (1986) Loss of tumor-suppressive function during chemically induced neoplastic progression of Syrian hamster embryo cells. Proc. Natl. Acad. Sci. U S A, 83, 5992-5996.
43. Oshimura, M. and Barrett, J. C. (1985) Double nondisjunction during karyotypic progression of chemically induced Syrian hamster cell lines. Cancer Genet. Cytogenet., 18, 131-139.
44. Oshimura, M., Hesterberg, T. W. and Barrett, J. C. (1986) An early, nonrandom karyotypic change in immortal Syrian hamster cell lines transformed by asbestos: trisomy of chromosome 11. Cancer Genet. Cytogenet., 22, 225-237.
45. Endo, S. and Hieber, L. (1995) Chromosome alterations that correlate with progression to immortality in Syrian hamster embryo cells transformed by gamma-irradiation. Int. J. Radiat. Biol., 67, 177-186.
46. Suzuki, K., Suzuki, F., Nikaido, O. and Watanabe, M. (1991) Suppression of differentiation phenotypes in myogenic cells: association of aneuploidy and altered regulation of c-myc gene expression. Exp. Cell Res., 195, 416-422.
47. Afshari, C. A., Kodama, S., Bivins, H. M., Willard, T. B., Fujiki, H. and Barrett, J. C. (1993) Induction of neoplastic progression in Syrian hamster embryo cells treated with protein phosphatase inhibitors. Cancer Res., 53, 1777-1782.
48. Watanabe, M., Suzuki, K. and Kodama, S. (1990) Karyotypic changes with neoplastic conversion in morphologically transformed golden hamster embryo cells induced by X-rays. Cancer Res., 50, 760-765.
49. Barrett, J. C. and Wiseman, R. W. (1987) Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogen risk assessment. Environ. Health Perspect., 76, 65-70.
50. Oshimura, M., Gilmer, T. M. and Barrett, J. C. (1985) Nonrandom loss of chromosome 15 in Syrian hamster tumours induced by v-Ha-ras plus v-myc oncogenes. Nature, 316, 636-639.
51. Futreal, P. A. and Barrett, J. C. (1991) Failure of senescent cells to phosphorylate the RB protein. Oncogene, 6, 1109-1113.
52. Sugawara, O., Oshimura, M., Koi, M., Annab, L. A. and Barrett, J. C. (1990) Induction of cellular senescence in immortalized cells by human chromosome 1. Science, 247, 707-710.
53. Nguyen-Ba, G. and Vasseur, P. (1999) Epigenetic events during the process of cell transformation induced by carcinogens (review). Oncol. Rep., 6, 925-932.
54. Nguyen-Ba, G., Dhalluin, S., Elias, Z., Tapiero, H., Poirot, O. and Hornebeck, W. (1993) Overinduction of ornithine decarboxylase and intracellular proteinase in SHE transformed cells. In Li F. P. and Montesano R. (eds.), Interaction of Cancer Susceptibility Genes and Environmental Carcinogens. Joint meeting AACR and IARC, Lyon, France, a19.
55. Lansing, T. J., Turk, B. F., Kanner, S. B. and Gilmer, T. M. (1997) Mutational activation of pp.60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line. Cancer Res., 57, 1962-1969.
56. Gilmer, T. M., Lamb, P. W., Oshimura, M. and Barrett, J. C. (1987) Correlation of V-src gene amplification with the tumorigenic phenotype in a Syrian hamster embryo cell line. Cancer Res., 47, 4663-4666.
57. Albor, A., Flessate, D. M., Soussi, T. and Notario, V. (1994) 3- Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation. Cancer Res., 54, 4502-4507.
58. Preston, G. A., Lang, J. E., Maronpot, R. R. and Barrett, J. C. (1994) Regulation of apoptosis by low serum in cells of different stages of neoplastic progression: enhanced susceptibility after loss of a senescence gene and decreased susceptibility after loss of a tumor suppressor gene. Cancer Res., 54, 4214-4223.
59. Takahashi, M., Barrett, J. C. and Tsutsui, T. (2002) Transformation by inorganic arsenic compounds of normal Syrian hamster embryo cells into a neoplastic state in which they become anchorage-independent and cause tumors in newborn hamsters. Int. J. Cancer, 99, 629-634.
60. Ebert, R., Barrett, J. C., Wiseman, R. W., Pechan, R., Reiss, E., Rö llich, G. and Schiffmann, D. (1990) Activation of cellular oncogenes by chemical carcinogens in Syrian hamster embryo fibroblasts. Environ. Health Perspect., 88, 175-178.
61. Velasco, J. A., Castro, R., Avila, M. A., Laborda, J., DiPaolo, J. A., Cansado, J. and Notario, V. (1994) cph, a novel oncogene which cooperates with H-ras in the transformation of NIH3T3 fibroblasts. Oncogene, 9, 2065-2069.
62. Notario, V., Castro, R., Flessate, D. M., Doniger, J. and Di Paolo, J. A. (1990) Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens. Oncogene, 5, 1425-1430.
63. Ebert, R., Wiseman, R. W., Barrett, J. C., Reiss, E., Rollich, G. and Schiffmann, D. (1992) Characterization of the Syrian hamster c-Ha-ras gene and intron-D-exon transcript. Mol. Carcinog., 5, 254-258.
64. Ashra, H. and Rao, K. V. (2006) Elevated phosphorylation of Chk1 and decreased phosphorylation of Chk2 are associated with abrogation of G2/M checkpoint control during transformation of Syrian hamster embryo (SHE) cells by malachite green. Cancer Lett., 237, 188-198.
65. Hartwell, L. H. and Weinert, T. A. (1989) Checkpoints: controls that ensure the order of cell cycle events. Science, 246, 629-634.
66. Tchevkina, E., Agapova, L., Dyakova, N., Martinjuk, A., Komelkov, A. and Tatosyan, A. (2005) The small G-protein RalA stimulates metastasis of transformed cells. Oncogene, 24, 329-335.
67. Mundy, G. R. (1997) Mechanisms of bone metastasis. Cancer, 80, 1546-1556.
68. Nannuru, K. C. and Singh, R. K. (2010) Tumor-stromal interactions in bone metastasis. Curr. Osteoporos. Rep., 8, 105-113.
69. Sethi, T., Rintoul, R. C., Moore, S. M. et al. (1999) Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat. Med., 5, 662-668.
70. Zacharski, L. R., Memoli, V. A., Orstein, D. L. et al. (1993) Tumor cell procoagulant and urokinase expression in carcinoma of the ovary. J. Natl. Cancer Inst., 85, 1225.
71. Rao, V. M. (1992) Tissue factor as a tumor procoagulant. Cancer Metastasis Rev., 11, 249.
72. Koh, S. C., Tham, K. F., Razvi, K., Oei, P. L., Lim, F. K., Roy, A. C. and Prasad, R. N. (2001) Hemostatic and fibrinolytic status in patients with ovarian cancer and benign ovarian cysts: could D-dimer and antithrombin III levels be included as prognostic markers for survival outcome? Clin. Appl. Thromb. Hemost., 7, 141-148.
73. Ossowski, L. and Reich, E. (1983) Antibodies to plasminogen activator inhibit tumor metastasis. Cell, 35, 611-619.
74. Quigley, J. P. (1979) Proteolytic enzymes of normal and malignant cells. In Heynes, R. O. (ed.), Surfaces of Normal and Malignant Cells. Wiley & Sons, London, UK, pp. 247-285.
75. Mullins, D. E. and Rohrlich, S. T. (1983) The role of proteinases in cellular invasiveness. Biochim. Biophys. Acta, 695, 177-214.
76. Markus, G. (1984) The role of homeostasis and fibrinolysis in the metastatic spread of cancer. Semin. Thromb. Hemost., 10, 61-70.
77. Kok, K., Osinga, J., Schotanus, D. C., Berendsen, H. H., de Leij, L. F. and Buys, C. H. (1989) Amplification and expression of different myc-family genes in a tumor specimen and 3 cell lines derived from one small-cell lung cancer patient during longitudinal follow-up. Int. J. Cancer, 44, 75-78.
78. Peterkofsky, B. and Prather, W. (1992) A post-translational modification, unrelated to hydroxylation, in the collagenous domain of nonhelical proalpha 2(I) procollagen chains secreted by chemically transformed hamster fibroblasts. J. Biol. Chem., 267, 5388-5395.
79. Lavnikova, N. A. and Burdelia, L. G. (1990) Susceptibility of cells with different stage of malignancy to cytostatic action of resident peritoneal macrophages of Syrian hamsters. Biull. Eksp. Biol. Med., 110, 83-85.
80. Volpe, E. A. (1992) Resistance of in vivo-selected spontaneously transformed cells and Rous sarcoma virus-transformed cells to macrophage-mediated cytotoxicity. Experientia, 48, 500-503.
81. Bos, J. L. (1989) Ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689.
82. Malumbres, M. and Barbacid, M. (2003) RAS oncogenes: the first 30 years. Nat. Rev. Cancer, 3, 459-465.
83. Chambers, A. F., Groom, A. C. and MacDonald, I. C. (2002) Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer, 2, 563-572.
84. Chambers, A. F. and Tuck, A. B. (1993) Ras-responsive genes and tumor metastasis. Crit. Rev. Oncog., 4, 95-114.
85. Oakman, C., Tenori, L., Biganzoli, L., Santarpia, L., Cappadona, S., Luchinat, C. and Di Leo, A. (2010) Uncovering the metabolomic fingerprint of breast cancer. Int. J. Biochem. Cell Biol., 43, 1010-1020.
86. Beckonert, O., Coen, M., Keun, H. C., Wang, Y., Ebbels, T. M., Holmes, E., Lindon, J. C. and Nicholson, J. K. (2010) High-resolution magic-angle spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat. Protoc., 5, 1019-1032.
87. Martin, F. L., Kelly, J. G., Llabjani, V., Martin-Hirsch, P. L., Patel, I. I., Trevisan, J., Fullwood, N. J. and Walsh, M. J. (2010) Distinguishing cell types or populations based on the computational analysis of their infrared spectra. Nat. Protoc., 5, 1748-1760.
88. Kelly, J. G., Cheung, K. T., Martin, C., O'Leary, J. J., Prendiville, W., Martin-Hirsch, P. L. and Martin, F. L. (2010) A spectral phenotype of oncogenic human papillomavirus-infected exfoliative cervical cytology distinguishes women based on age. Clin. Chim. Acta, 411, 1027-1033.
89. Al-Majid, S. and Waters, H. (2008) The biological mechanisms of cancerrelated skeletal muscle wasting: the role of progressive resistance exercise. Biol. Res. Nurs., 10, 7-20.
90. Argilés, J. M., López-Soriano, F. J. and Busquets, S. (2007) Mechanisms to explain wasting of muscle and fat in cancer cachexia. Curr. Opin. Support. Palliat. Care, 1, 293-298.
91. Gatenby, R. A. and Gillies, R. J. (2004) Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer, 4, 891-899.
92. Nam, H., Chung, B. C., Kim, Y., Lee, K. and Lee, D. (2009) Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics, 25, 3151-3157.
93. Kim, J. W. and Dang, C. V. (2006) Cancer's molecular sweet tooth and the Warburg effect. Cancer Res., 66, 8927-8930.
94. Yeh, C. S., Cheng, T. L., Juan, C. H., Wu, C. H. and Lin, S. R. (2006) Fatty acid metabolism pathway plays an important role in carcinogenesis of human colorectal cancers by Microarray-Bioinformatics analysis. Cancer Lett., 233, 297-308.
95. Fullwood, N. J., Martin, F. L., Bentley, A. J., Lee, J. P. and Lee, S. J. (2011) Imaging sclera with hard X-ray microscopy. Micron, 42, 506-511.
96. Fullwood, N. J. and Meek, K. M. (1993) A synchroton X-ray study of the changes occurring in the corneal stroma during processing for electron microscopy. J. Microsc., 169, 53-60.
97. Martin, F. L. (2011) Shining a light into molecular workings. Nat. Methods, 8, 385-387.
98. German, M. J., Hammiche, A., Ragavan, N. et al. (2006) Infrared spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell. Biophys. J., 90, 3783-3795.
99. - modifications as a marker of the putative stem cell region of human intestinal crypts. Stem Cells, 26, 108-118.
100. Bi, X., Walsh, M. J., Wei, X., Sheng, G., Fu, J., Martin-Hirsch, P. L., Thomas, G. O., Jones, K. C. and Martin, F. L. (2007) Infrared spectral analysis of MCF-7 cells treated with serum-lipid extracts segregates predominantly brominated flame retardant-exposed subjects from those with mainly organochlorine exposures. Environ. Sci. Technol., 41, 5915-5922.
101. Llabjani, V., Jones, K. C., Thomas, G. O., Walker, L. A., Shore, R. F. and Martin, F. L. (2009) Polybrominated diphenyl ether-associated alterations in cell biochemistry as determined by attenuated total reflection Fouriertransform infrared spectroscopy: a comparison with DNA-reactive and/or endocrine-disrupting agents. Environ. Sci. Technol., 43, 3356-3364.
102. Barber, J. L., Walsh, M. J., Hewitt, R., Jones, K. C. and Martin, F. L. (2006) Low-dose treatment with polybrominated diphenyl ethers (PBDEs) induce altered characteristics in MCF-7 cells. Mutagenesis, 21, 351-360.
103. Llabjani, V., Trevisan, J., Jones, K. C., Shore, R. F. and Martin, F. L. (2010) Binary mixture effects of PBDE congeners (47, 153, 183, or 209) and PCB congeners (126 or 153) in MCF-7 cells: biochemical alterations assessed by IR spectroscopy and multivariate analysis. Environ. Sci. Technol., 44, 3992-3998.
104. Kelly, J. G., Trevisan, J., Scott, A. D., Carmichael, P. L., Pollock, H. M., Martin-Hirsch, P. L. and Martin, F. L. (2011) Biospectroscopy to metabolically profile biomolecular structure: a multistage approach linking computational analysis with biomarkers. J. Proteome Res., 10, 1437-1448.
105. Trevisan, J., Angelov, P. P., Patel, I. I. et al. (2010) Syrian hamster embryo (SHE) assay (pH 6.7) coupled with infrared spectroscopy and chemometrics towards toxicological assessment. Analyst, 135, 3266-3272.
106. Creton, S., Aardema, M. J., Carmichael, P. L. et al. Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs. Mutagenesis, 27, 93-101.